Hepatitis C virus associated polyarteritis nodosa

Arthritis Care and Research

Volumn 63, Issue 3, 2011, Pages 427-435

  Saadoun, D ^a   Terrier, B ^a   Semoun, O ^b,c   Sene, D ^a   Maisonobe, T ^a   Musset, L ^a   Amoura, Z ^a   Rigon, M Resche ^b,c   Cacoub, P ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c SAINT LOUIS HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; IMMUNOSUPPRESSIVE AGENT;

ACUTE DISEASE; ADULT; AGED; ANEURYSM; ARTICLE; CLINICAL ARTICLE; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; CRYOGLOBULINEMIA; DIGESTIVE SYSTEM INFLAMMATION; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; FEVER; GLOMERULUS FILTRATION RATE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HYPERTENSION; MALE; MICROANEURYSM; MONONEUROPATHY; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; POLYARTERITIS NODOSA; REMISSION; RISK; SKIN INFLAMMATION; SURVIVAL RATE; UNIVERSITY HOSPITAL; WEIGHT REDUCTION; FRANCE; HOSPITALIZATION; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; TIME; TREATMENT OUTCOME; VIROLOGY;

AGED; FEMALE; HEPATITIS C; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PARIS; POLYARTERITIS NODOSA; PROPORTIONAL HAZARDS MODELS; REMISSION INDUCTION; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME;

EID: 79958024738     PISSN: 00043591     EISSN: 21514658     Source Type: Journal    
DOI: 10.1002/acr.20381     Document Type: Article

References (34)

1. Lie JT. Nomenclature and classification of vasculitis: plus ça change, plus c'est la même chose. Arthritis Rheum 1994;37: 181-6. (Pubitemid 24065491)
2. Meltzer M, Franklin EC, Elias K, McCluskey RT, Cooper N. Cryoglobulinemia: a clinical and laboratory study. II. Cryo-globulins with rheumatoid factor activity. Am J Med 1966;40: 837-56.
3. Gorevic PD, Kassab HJ, Levo Y, Kohn R, Meltzer M, Prose P, et al. Mixed cryoglobulinemia: clinical aspects and long-term follow-up of 40 patients. Am J Med 1980;69:287-308. (Pubitemid 10036826)
4. Somer T, Finegold SM. Vasculitides associated with infections, immunization, and antimicrobial drugs. Clin Infect Dis 1995;20:1010-36.
5. Levo Y, Gorevic PD, Kassab HJ, Zucker-Franklin D, Franklin EC. Association between hepatitis B virus and essential mixed cryoglobulinemia. N Engl J Med 1977;296:1501-4. (Pubitemid 8140562)
6. Kussmaul A, Maier R. Ueber eine bisher nicht beschriebene eigenthümliche arterienerkrankung (periarteritis nodosa), die mit morbus brightii und rapid fortschreitender allgemeiner muskellähmung einhergeht. Dtsch Arch Klein Med 1866;1: 484-518.
7. Cacoub P, Maisonobe T, Thibault V, Gatel A, Servan J, Musset L, et al. Systemic vasculitis in patients with hepatitis C. J Rheumatol 2001;28:109-18. (Pubitemid 32062032)
8. Cacoub P, Lunel-Fabiani F, Du LT. Polyarteritis nodosa and hepatitis C virus infection letter. Ann Intern Med 1992;116: 605-6.
9. Carson CW, Conn DL, Czaja AJ, Wright TL, Brecher ME. Frequency and significance of antibodies to hepatitis C virus in polyarteritis nodosa. J Rheumatol 1993;20:304-9. (Pubitemid 23066043)
10. Quint L, Deny P, Guillevin L, Granger B, Jarrousse B, Lhote F, et al. Hepatitis C virus in patients with polyarteritis nodosa: prevalence in 38 patients. Clin Exp Rheumatol 1991;9:253-7.
11. Jennette JC, Falk RJ, Andrassy K, Bacon PA, Churg J, Gross WL, et al. Nomenclature of systemic vasculitides: proposal of an international consensus conference. Arthritis Rheum 1994; 37:187-92. (Pubitemid 24065492)
12. Lightfoot RW Jr, Michel BA, Bloch DA, Hunder GG, Zvaifler NJ, McShane DJ, et al. The American College of Rheumatology 1990 criteria for the classification of polyarteritis nodosa. Arthritis Rheum 1990;33:1088-93. (Pubitemid 20273292)
13. Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J, et al. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting; Airlie House, Virginia, November 1997. J Clin Oncol 1999;17: 3835-49.
14. Luqmani RA, Bacon PA, Moots RJ, Janssen BA, Pall A, Emery P, et al. Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis. QJM 1994;87:671-8. (Pubitemid 24334817)
15. Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C: the French METAVIR Cooperative Study Group. Hepatology 1994;20:15-20.
16. Musset L, Diemert MC, Taibi F, Thi Huong Du L, Cacoub P, Leger JM, et al. Characterization of cryoglobulins by immu-noblotting. Clin Chem 1992;38:798-802.
17. Brouet JC, Clauvel JP, Danon F, Klein M, Seligmann M. Biologic and clinical significance of cryoglobulins: a report of 86 cases. Am J Med 1974;57:775-88.
18. Guillevin L, Mahr A, Callard P, Godmer P, Pagnoux C, Leray E, et al. Hepatitis B virus-associated polyarteritis nodosa: clinical characteristics, outcome, and impact of treatment in 115 patients. Medicine (Baltimore) 2005;84:313-22. (Pubitemid 41368484)
19. Saadoun D, Resche-Rigon M, Thibault V, Piette JC, Cacoub P. Antiviral therapy for hepatitis C virus-associated mixed cryo-globulinemia vasculitis: a long-term followup study. Arthritis Rheum 2006;54:3696-706. (Pubitemid 44737183)
20. Le Cessie S, van Houwelingen HC. Testing the fit of a regression model via score tests in random effects models. Biometrics 1995;51:600-14.
21. Fine JP, Gray RJ. A proportional hazards model for the sub-distribution of a competing risk. JAMA 1999;94:496-509.
22. Ramos-Casals M, Munoz S, Medina F, Jara LJ, Rosas J, Calvo-Alen J, et al. Systemic autoimmune diseases in patients with hepatitis C virus infection: characterization of 1020 cases (the HISPAMEC Registry). J Rheumatol 2009;36:1442-8.
23. Tarantino A, Campise M, Banfi G, Confalonieri R, Bucci A, Montoli A, et al. Long-term predictors of survival in essential mixed cryoglobulinemic glomerulonephritis. Kidney Int 1995;47:618-23.
24. Ferri C, Sebastiani M, Giuggioli D, Cazzato M, Longombardo G, Antonelli A, et al. Mixed cryoglobulinemia: demographic, clinical, and serologic features and survival in 231 patients. Semin Arthritis Rheum 2004;33:355-74. (Pubitemid 38887136)
25. Fauci AS, Haynes B, Katz P. The spectrum of vasculitis: clinical, pathologic, immunologic and therapeutic considerations. Ann Intern Med 1978;89:660-76. (Pubitemid 9037756)
26. Pagnoux C, Seror R, Henegar C, Mahr A, Cohen P, Le Guern V, et al, for the French Vasculitis Study Group. Clinical features and outcomes in 348 patients with polyarteritis nodosa: a systematic retrospective study of patients diagnosed between 1963 and 2005 and entered into the French Vasculitis Study Group Database. Arthritis Rheum 2010;62:616-26.
27. Saadoun D, Bieche I, Maisonobe T, Asselah T, Laurendeau I, Piette JC, et al. Involvement of chemokines and type 1 cyto-kines in the pathogenesis of hepatitis C virus-associated mixed cryoglobulinemia vasculitis neuropathy. Arthritis Rheum 2005;52:2917-25. (Pubitemid 41369123)
28. Authier FJ, Bassez G, Payan C, Guillevin L, Pawlotsky JM, Degos JD, et al. Detection of genomic viral RNA in nerve and muscle of patients with HCV neuropathy. Neurology 2003;60: 808-12. (Pubitemid 36297365)
29. Nemni R, Sanvito L, Quattrini A, Santuccio G, Camerlingo M, Canal N. Peripheral neuropathy in hepatitis C virus infection with and without cryoglobulinaemia. J Neurol Neurosurg Psychiatry 2003;74:1267-71.
30. Saadoun D, Bieche I, Authier FJ, Laurendeau I, Jambou F, Piette JC, et al. Role of matrix metalloproteinases, proinflam-matory cytokines, and oxidative stress-derived molecules in hepatitis C virus-associated mixed cryoglobulinemia vascu-litis neuropathy. Arthritis Rheum 2007;56:1315-24. (Pubitemid 46608657)
31. Pawlotsky JM, Roudot-Thoraval F, Simmonds P, Mellor J, Ben Yahia MB, Andre C, et al. Extrahepatic immunologic manifestations in chronic hepatitis C and hepatitis C virus sero-types. Ann Intern Med 1995;122:169-73.
32. Saadoun D, Asselah T, Resche-Rigon M, Charlotte F, Bedossa P, Valla D, et al. Cryoglobulinemia is associated with steatosis and fibrosis in chronic hepatitis C. Hepatology 2006;43:1337-45. (Pubitemid 43980113)
33. Rigolet A, Cacoub P, Schnuriger A, Vallat L, Cahour A, Ghil-lani P, et al. Genetic heterogeneity of the hypervariable region I of hepatitis C virus and lymphoproliferative disorders. Leukemia 2005;19:1070-6. (Pubitemid 40867266)
34. Prince AM, Trepo C. Role of immune complexes involving SH antigen in pathogenesis of chronic active hepatitis and poly-arteritis nodosa. Lancet 1971;1:1309-12.